Medical News

RSS
Danish researchers face possible breakthrough in fight against cancer

Danish researchers face possible breakthrough in fight against cancer

UW researchers use noninvasive light-based imaging technology to see inside the living brain

UW researchers use noninvasive light-based imaging technology to see inside the living brain

Sleep apnea associated with evidence of early heart injury in women

Sleep apnea associated with evidence of early heart injury in women

High Intensity Focused Ultrasound treatment now available in the U.S. to treat prostate cancer

High Intensity Focused Ultrasound treatment now available in the U.S. to treat prostate cancer

RE.WORK showcases future technology and innovations in deep learning software

RE.WORK showcases future technology and innovations in deep learning software

SilverScript announces new Medicare Prescription Drug Plan options for 2016

SilverScript announces new Medicare Prescription Drug Plan options for 2016

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

XTL signs agreement with Yeda to amend development milestones for lupus treatment

XTL signs agreement with Yeda to amend development milestones for lupus treatment

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

Research shows one in three young men in China could die from tobacco use

Research shows one in three young men in China could die from tobacco use

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Hands-free smartphones can simplify intravenous injection procedures

Hands-free smartphones can simplify intravenous injection procedures

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.